Dabigatran vs Rituximab

## Dabigatran vs Rituximab: Overview

This comparison examines the pharmacological differences between **Dabigatran** and **Rituximab**.

## Mechanism of Action

**Dabigatran**: Direct thrombin (Factor IIa) inhibitor.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Dabigatran — 12-17 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Dabigatran — C25H25N7O3; Rituximab — N/A.

**Molecular Weight**: Dabigatran — 471.5100 g/mol; Rituximab — N/A.

**Type**: Dabigatran — Small molecule; Rituximab — Antibody.